Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Triumph Capital Management »

Regeneron Pharmaceuticals shares owned by Triumph Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Triumph Capital Management from 13F filings

Historical chart of Triumph Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Triumph Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Triumph Capital Management

Quarter filed	Position value	Share count	Share price at filing
2025-09-30	$262k	465	562.44
2025-06-30	$443k	843	525.06
2025-03-31	$376k	592	634.27
2024-12-31	$399k	560	712.33
2024-09-30	$445k	423	1051.24

More positions owned by Triumph Capital Management

First Trust Enhanced Short Maturity Etf First Tr Enh New (FTSM)

First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)

First Tr Exchange Traded Risng Divd Achiv (RDVY)

First Tr Exchange-traded Cap Strength Etf (FTCS)

Vanguard Bd Index Fds Total Bnd Mrkt (BND)

First Tr Exchange-traded Smid Risng Etf (SDVY)

Spdr S&p 500 Etf Tr Tr Unit (SPY)

Jpmorgan Ultra-short Income Etf Etf (JPST)

Invesco Qqq Tr Unit Ser 1 (QQQ)

Ishares Tr Core S&p500 Etf (IVV)

First Tr Exchange-traded SHS (FDL)

First Trust Low Duration Opportunities Etf Oppt Eft (LMBS)

First Tr Exchange-traded A Com Shs (FEX)

NVIDIA Corporation (NVDA)

Ishares Tr Rus Mid Cap Etf (IWR)

View all positions for Triumph Capital Management

Top funds holding Regeneron Pharmaceuticals

State Street Corporation

Jpmorgan Chase & Co

Geode Capital Management

Franklin Resources

Capital World Investors

Loomis, Sayles and

Susquehanna International

Goldman Sachs Group

View all funds holding Regeneron Pharmaceuticals

© 2025 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z